基于网络药理学验证猴头菌改善酒精性肝损伤OA
Validation of Hericium erinaceum in Alleviating Alcoholic Liver Injury Based on Network Pharmacology
通过网络药理学及体内实验探讨猴头菌提取物改善酒精性肝损伤的作用机制.采用网络药理学技术获取猴头菌提取物改善酒精性肝损伤的核心靶点和信号通路.将48只斯普雷格-道利(Sprague-Dawley,SD)大鼠随机分为正常组、模型组、阳性药对照组及猴头菌提取物低、中、高剂量组,采用50%体积分数的酒精建立肝损伤模型.猴头菌提取物低、中、高剂量组每天分别灌胃1、2、4 mg·kg⁻¹,阳性对照组每天给多烯磷脂酰胆碱 50 mg·kg⁻¹.干预3周后,采用苏木精-伊红(Hematoxylin and Eosin,HE)染色观察肝组织病理变化,酶联染色吸附试验(Enzyme-linked Immunosorbent Assay,ELISA)检测丙二醛(Malondialdehyde,MDA)、谷胱甘肽过氧化物酶(Glutathione Per-oxidase,GSH-PX)、超氧化物歧化酶(Superoxide Dismutase,SOD)、过氧化氢酶(Catalase,CAT)抗氧化因子水平,Western blot检测p38丝裂原活化蛋白激酶/核因子κB(p38 Mitogen-activated Protein Kinase/Nuclear Factor kappa-B,p38MAPK/NF-κB)信号通路相关蛋白表达水平.网络药理学筛选获得猴头菌提取物主要以猴头菌素、猴头菌酮、大黄酚等为关键成分,作用于肿瘤蛋白p53(Tumor Protein p53,TP53)、蛋白激酶Bα(Protein Kinase B alpha,AKT1)、信号转导与转录激活因子3(Signal Transducer and Activator of Transcription 3,STAT3)、表皮生长因子受体(Epidermal Growth Factor Receptor,EGFR)和丝裂原活化蛋白激酶 14(Mitogen-activated Protein Kinase 14,MAPK14)等靶标蛋白,调控MAPK/NF-κB、TNF等信号通路发挥抗氧化、抗炎作用.体内实验结果表明猴头菌提取物能显著降低肝组织中MDA因子水平,升高 GSH-PX、SOD、CAT 水平,改善大鼠肝脏病理损伤,降低酒精性肝损伤大鼠肝脏组织中p-p38MAPK 和p-NF-κB p65、TNF蛋白相对表达量(P<0.05).猴头菌提取物对酒精性肝损伤大鼠的改善作用主要体现在改善肝脏病理改变、降低肝脏组织中的氧化炎症因子水平等方面,其作用机制可能与调控 p38MAPK/NF-κB 信号通路有关.
The purpose of this study was to explore the potential mechanism of Hericium erinaceum extract in alleviating alcoholic liver injury through the combination of network pharmacology and experimental validation.Network pharmacology technology iden-tified the core targets and signaling pathways of Hericium erinaceum extract in the treatment of alcoholic liver injury.SD rats were randomly divided into 6 groups:control group(Con),model group(Mod),positive drug group(PC),low dose(L)group,middle dose(M)group,high dose(H)group.A rat model of chronic alcoholic liver injury was established by intragastric administration of 50%ethanol solution every other day for 3 weeks.The positive control group was treated with Polyene Phosphatidylcholine 50 mg·kg⁻¹ per day,the low-,medium-,and high-dose groups were given intragastric administration of 1,2,and 4 mg·kg⁻¹ per day,respectively.After 3 weeks of intervention,hematoxylin-eosin(HE)staining was used to observe the pathological changes of liver tissue,ELISA was employed to measure the levels of oxidative and inflammatory factors,and western blot was used to detect the ex-pression of related proteins.Network pharmacological analysis obtained that Hericium erinaceum extract mainly takes Erinacine(Hericenone),Hericene,and chrysophanic acid as the key components,which act on the target proteins such as TP53,AKT1,STAT3,EGFR,MAPK14,and regulate the signaling pathways of MAPK/NF-κB and TNF.The in vivo experimental showed that Hericium erinaceum extract could significantly reduced the level of oxidative factor MDA in liver tissue,increased the levels of GSH-PX,SOD,and CAT,improved pathological liver damage in rats,and decreased the relative expression levels of p-p38MAPK,p-NF-κB p65,and TNF proteins in liver tissue of rats with alcoholic liver injury(P<0.05).It is suggested that Hericium erinaceum extract can ameliorate alcohol-induced liver injury,and the mechanism may be related to the regulation of the p38MAPK/NF-κB signaling path-way.
张文芳;任钰佳;杨浩然;吕晶鑫;李文静;马乾;李震宇;秦楠
山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 中药与食品工程学院,山西 晋中 030619山西中医药大学 中药与食品工程学院,山西 晋中 030619山西大学 中医药现代研究中心,山西 太原 030006山西中医药大学 中药与食品工程学院,山西 晋中 030619
医药卫生
猴头菌酒精性肝损伤网络药理学p38-MAPK/NF-κB
Hericium erinaceumalcoholic liver injurynetwork pharmacologyp38-MAPK/NF-κB
《山西大学学报(自然科学版)》 2026 (5)
803-814,12
山西省自然科学基金(202303021222202)山西省高等学校科技创新项目(2023L194)山西中医药大学优秀博士毕业生来晋工作奖励科研启动基金项目(2023BKS23)山西中医药大学博士科研启动资金(2023BK10)
评论